CV Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Details Narrative)

STOCK-BASED COMPENSATION (Details Narrative) $ / shares in Units, $ in Millions				1 Months Ended			3 Months Ended		6 Months Ended
	Jan. 01, 2020 shares	Jun. 11, 2019 shares	Jan. 22, 2019	Jun. 30, 2020 USD ($) $ / shares shares	Mar. 31, 2017 shares	Jul. 31, 2016 shares	Jun. 30, 2020 USD ($) shares	Jun. 30, 2019 USD ($) company	Jun. 30, 2020 USD ($) company $ / shares shares	Jun. 30, 2019 USD ($)	Jun. 20, 2020 USD ($)	Dec. 31, 2019 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost \| $				$ 4.3			$ 4.3		$ 4.3
Unrecognized weighted average period									1 year 8 months 12 days
Number of companies in the peer group used in the calculation of volatility \| company								5	5
Former President and CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Extension of period to exercise stock options			5 years
Options outstanding, granted (shares)					5,000,000	6,000,000
Options and RSU's \| Operating Income (Loss)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense \| $							$ 1.2	$ 2.1	$ 2.5	$ 12.1
Restricted Stock Units (RSUs) \| Former President and CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense \| $										5.1
Stock options \| Operating Income (Loss)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of stock options exercised in the period \| $									$ 0.3	4.1
Stock options \| Former President and CEO
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense \| $										$ 2.7
Stock Option Modification
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation expense \| $				$ 0.1
Options outstanding, granted (shares)				2,130,000
Weighted average exercise price, granted (in USD per share) \| $ / shares				$ 0.66
Unrecognized compensation cost \| $											$ 0.2
Options Outside the Amended 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance-based options outstanding (shares)				5,000,000			5,000,000		5,000,000
Unvested stock options outstanding (shares)				8,000,000			8,000,000		8,000,000
Equity Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding, granted (shares)									6,105,000
Weighted average exercise price, granted (in USD per share) \| $ / shares									$ 0.41
Performance-based options outstanding (shares)				26,661,000			26,661,000		26,661,000			28,105,000
Amended 2013 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized (shares)	3,976,000	3,000,000
Annual increase to shares authorized for issuance under the Plan as percent of common stock outstanding (shares)		4.00%
Annual increase to shares authorized for issuance under the Plan (shares)		4,000,000
Shares authorized under plan (shares)				34,976,000			34,976,000		34,976,000
Authorized unissued shares reserved and available for issuance upon exercise and conversion of outstanding awards (shares)				4,872,000			4,872,000		4,872,000